The second episode of The ConcertAI Podcast features Dr. Sibel Blau and Caroline Merillat, key figures in the Quality Cancer Care Alliance (QCCA) and creators of Exigent. This initiative aims to improve clinical research in community oncology, making trials more accessible and reflective of standard care populations. Dr. Blau, motivated by a dream to cure cancer, emphasized the importance of maintaining the independence of oncology practices for superior patient care. Merillat, with extensive experience in research, is dedicated to expanding trial access, especially for underserved populations. Exigent, by leveraging real-world data and collaborative efforts, seeks to enhance trial quality and speed, emphasizing a patient-centric approach that prioritizes the right trials for patients. This innovative model showcases the potential of community oncology to lead in research and patient care, underscoring the significance of independent practices in the healthcare ecosystem.

Websitewww.ConcertAI.comLinkedInwww.linkedin.com/company/concertai/Twitterwww.twitter.com/concertai

Podden och tillhörande omslagsbild på den här sidan tillhör ConcertAI. Innehållet i podden är skapat av ConcertAI och inte av, eller tillsammans med, Poddtoppen.